Quoted Micro 3 August 2026
AQUIS STOCK EXCHANGE Ajax Resources (AJAX) has agreed to exchange the Rureka project and related assets for the Rachiate prospect and the El Salto project in Argentina. The deal and transaction structure are still to be finalised. No cash will be involved. Ajax was previously planning to acquire the Rachiate prospect. Ajax has also entered […]
Quoted Micro 6 July 2026
AQUIS STOCK EXCHANGE Lift Global Ventures (LFT) has bought a 2.18% stake in FourJaw Manufacturing Analytics, which is developing AI and machine learning technology for manufacturing, for £150,000 in shares at 1.5p each. The share price jumped 64.3% to 0.575p. WeCap (WCAP) investee company WeShop has been added to the US Russell 3000 index. Hot […]
Quoted Micro 11 May 2026
AQUIS STOCK EXCHANGE Newbury Racecourse (NYR) increased full year revenues by 6% to £23.4m, while pre-tax profit was flat at £1.1m. Race day attendances were one-quarter higher at 165,492. The final dividend is unchanged at 6p/share. Invinity Energy Systems (IES) is successfully reducing the cost of the Endurium vanadium flow battery technology and making other […]
Quoted Micro 10 November 2025
AQUIS STOCK EXCHANGE Asset and fund managers advisory services provider Falconedge (EDGE) joined Aquis on 5 November. The company was formed in 2024, and it has five clients. There was £1.44m raised at 1.034p/share. It previously raised £1m. Falconedge was valued at £10.5m on admission. Falconedge has already bought 15.16258228 Bitcoin at $103,553.97 each. The […]
Quoted Micro 20 October 2025
AQUIS STOCK EXCHANGE ProBiotix Health (PBX) increased sales 30% to £1.97m in the nine months to September 2025. There is sufficient cash for the company’s needs. A commercial partnership with RevivaBio has been set up to launch a new cholesterol lowering product powered by the ProBiotix patented probiotic strain LPLDL®. Chairman Adam Rynolds bought 100,000 […]
Quoted Micro 21 July 2025
AQUIS STOCK EXCHANGE Probiotics developer ProBiotix Health (LON: PBX) increased interim revenues by one-third to £1.34m and the loss was reduced. The first orders have been delivered to Kemin China Technology. The current order book is at record levels. There was £1.3m in cash at the end of June 2025. The full interims will be […]
Quoted Micro 14 October 2024
AQUIS STOCK EXCHANGE Cardio health probiotics products developer ProBiotix Health (PBX) increased sales by 39% to £1.53m and the gross profit margin is stable in the nine months to September 2024. This is due to a recent product launch on Amazon and in 2,000 Target stores. A commercial partnership with Mexico-based Raff should generate commercial […]
Quoted Micro 7 October 2024
AQUIS STOCK EXCHANGE Prize draw operator Good Life Plus (GDLF) has increased the number of paying subscribers by 90% to more than 40,000 in less than a year. Management says that it might exceed expectations for the current financial year. Good Life Plus is raising £2m at 2.5p/share. Earlier this year, £2m was raised at […]
Quoted Micro 9 September 2024
AQUIS STOCK EXCHANGE Good Life Plus (GDLF) raised £275,000 from a convertible loan note issue that expires on 31 August 2025 when it can be repaid at a 10% premium or converted into shares at a 10% discount to the weighted average price over the previous month. If there is £2m raised in a share […]
Quoted Micro 17 June 2024
AQUIS STOCK EXCHANGE Samarkand (SMK) has sold its probiotic brand of Probio7 for £1.3m with an initial cash payment of £1.1m. This will provide working capital for the company’s other healthcare brands. Unsecured loans made by the directors to finance the acquisition of Optimised Energetics will be repaid. Skin treatments developer Incanthera (INC) has moved […]